These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 28067150

  • 1. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L, Wang Y, Zheng H, Zhang D, Wu X, Sun G, Yang T.
    J Chemother; 2017 Jun; 29(3):179-188. PubMed ID: 28067150
    [Abstract] [Full Text] [Related]

  • 2. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 3. Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms.
    Charette N, De Saeger C, Horsmans Y, Leclercq I, Stärkel P.
    Cell Death Dis; 2013 Jan 24; 4(1):e471. PubMed ID: 23348585
    [Abstract] [Full Text] [Related]

  • 4. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M.
    Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621
    [Abstract] [Full Text] [Related]

  • 5. Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
    Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, Chen PJ, Cheng AL.
    Clin Cancer Res; 2010 Nov 01; 16(21):5189-99. PubMed ID: 20884624
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5.
    Zhang B, Shan H, Li D, Li ZR, Zhu KS, Jiang ZB, Huang MS.
    Oncol Rep; 2011 Feb 01; 25(2):461-8. PubMed ID: 21152876
    [Abstract] [Full Text] [Related]

  • 7. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul 01; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 8. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
    James MA, Seibel WL, Kupert E, Hu XX, Potharla VY, Anderson MW.
    Anticancer Drugs; 2015 Jun 01; 26(5):518-30. PubMed ID: 25646742
    [Abstract] [Full Text] [Related]

  • 9. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y, Harashima N, Tajima Y, Harada M.
    Oncotarget; 2015 Dec 08; 6(39):41902-15. PubMed ID: 26506422
    [Abstract] [Full Text] [Related]

  • 10. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.
    Jung KJ, Min KJ, Bae JH, Kwon TK.
    Oncotarget; 2015 Jan 30; 6(3):1556-68. PubMed ID: 25596735
    [Abstract] [Full Text] [Related]

  • 11. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
    Mol Cancer Ther; 2011 Oct 30; 10(10):1969-81. PubMed ID: 21817114
    [Abstract] [Full Text] [Related]

  • 12. α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation.
    Mota A, Jiménez-Garcia L, Herránz S, de Las Heras B, Hortelano S.
    Toxicol Appl Pharmacol; 2015 Aug 01; 286(3):168-77. PubMed ID: 25930665
    [Abstract] [Full Text] [Related]

  • 13. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 14. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
    He SQ, Chen Y, Chen XP, Zhang WG, Wang HP, Zhang BX.
    Zhonghua Wai Ke Za Zhi; 2003 Jun 15; 41(6):453-7. PubMed ID: 12895357
    [Abstract] [Full Text] [Related]

  • 15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X, Zhang K, Wang Q, Chen S, Gou Y, Cui Y, Li Q.
    Zhonghua Zhong Liu Za Zhi; 2015 Jun 15; 37(6):404-11. PubMed ID: 26463141
    [Abstract] [Full Text] [Related]

  • 16. The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo.
    Zhu H, Zhao F, Yu S, He J, Deng L, Yi C, Huang Y.
    Int J Mol Med; 2012 Nov 15; 30(5):1087-94. PubMed ID: 22922573
    [Abstract] [Full Text] [Related]

  • 17. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.
    Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ, Choi KS.
    Cancer Res; 2006 Feb 01; 66(3):1740-50. PubMed ID: 16452234
    [Abstract] [Full Text] [Related]

  • 18. Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells.
    Lim SC, Jeon HJ, Kee KH, Lee MJ, Hong R, Han SI.
    Int J Oncol; 2016 Nov 01; 49(5):1983-1990. PubMed ID: 27665736
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
    Lee JY, Jung KH, Morgan MJ, Kang YR, Lee HS, Koo GB, Hong SS, Kwon SW, Kim YS.
    Mol Cancer Ther; 2013 Mar 01; 12(3):274-85. PubMed ID: 23053497
    [Abstract] [Full Text] [Related]

  • 20. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY, Kim EH, Kim SU, Kwon TK, Choi KS.
    Carcinogenesis; 2010 Mar 01; 31(3):367-75. PubMed ID: 19939880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.